Debt-to-equity of VitaNova Life Sciences Corp from 31 Jul 2018 to 31 Oct 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
VitaNova Life Sciences Corp quarterly Debt-to-equity in % history and change rate from 31 Jul 2018 to 31 Oct 2025.
  • VitaNova Life Sciences Corp Debt-to-equity for the quarter ending 31 Oct 2025 was 20%, a 23% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

VitaNova Life Sciences Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 20% +3.8% +23% 31 Oct 2025
Q2 2025 20% +1.3% +6.9% 31 Jul 2025
Q1 2025 19% -3.7% -16% 30 Apr 2025
Q4 2024 18% -35% -65% 31 Jan 2025
Q3 2024 16% 31 Oct 2024
Q2 2024 18% 31 Jul 2024
Q1 2024 23% 30 Apr 2024
Q4 2023 53% 31 Jan 2024
Q2 2022 -236% -136% -136% 31 Jul 2022
Q1 2022 -205% -105% -105% 30 Apr 2022
Q4 2021 -132% -32% -32% 31 Jan 2022
Q3 2021 -108% -7.7% -7.6% 31 Oct 2021
Q2 2021 -100% +0.91% +0.9% 31 Jul 2021
Q1 2021 -100% +1.1% +1.1% 30 Apr 2021
Q4 2020 -100% +1.3% +1.3% 31 Jan 2021
Q3 2020 -101% -16% -18% 31 Oct 2020
Q2 2020 -101% -24% -31% 31 Jul 2020
Q1 2020 -101% +46% +31% 30 Apr 2020
Q4 2019 -101% -241% 31 Jan 2020
Q3 2019 -85% -169% 31 Oct 2019
Q2 2019 -77% -169% -183% 31 Jul 2019
Q1 2019 -148% 30 Apr 2019
Q4 2018 140%* 31 Jan 2019
Q3 2018 84%* 31 Oct 2018
Q2 2018 93% 31 Jul 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.